Anika Therapeutics, Inc.

Anika Therapeutics is a global joint preservation company specializing in early intervention orthopedics. The company focuses on the development, manufacturing, and commercialization of hyaluronic acid (HA) innovations to treat osteoarthritis pain and provide regenerative solutions for tissue repair and healing. Headquartered in Bedford, Massachusetts, Anika's portfolio includes well-known products such as Monovisc, Orthovisc, and Cingal for pain management, as well as regenerative tissue repair solutions like Hyalofast and Tactoset. The company operates internationally and maintains a strong focus on clinical research and regulatory pathways to expand its orthopedic and regenerative medicine offerings.